16 CFR 1702.15
§ 1702.15 Petitions alleging the incompatibility of child resistant packaging with the particular substance petitioned for exemption.
United States · 16 CFR — Commercial Practices · Status: effective
Cite this
- Citation
- 16 CFR 1702.15, § 1702.15 Petitions alleging the incompatibility of child resistant packaging with the particular substance petitioned for exemption, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/66353
- Permanent ID
ys:prov:66353@1- SHA-256
dd82e03c0424bb23eeb1841f962ba0a47450b10b638cfad8b28607a69ef48630
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Where the petition for an exemption is based upon an allegation that the applicable special packaging standard is incompatible with the particular substance or would seriously and adversely compromise the utility or stability of a substance, the petitioner shall submit adequate evidence to support the allegation.
(b) If the allegation of incompatibility is based upon the fact that package choice is limited by a new drug application filed with the FDA, the petition shall state the limitation of package choice and a description of a time schedule to revise the NDA in order to allow additional package choice.
(c) If the allegation of incompatibility is based upon the fact that the shelf life of the product limits package choice, the petition shall outline the particular limitation and shall include a description of a time schedule to re-establish shelf-life data.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.